CSE’s Barrington Miller was recently joined in the studio by Dr. Raza Bokhari, CEO of FSD Pharma (CSE:HUGE), whose company recently celebrated their market open at the Canadian Securities Exchange.
In this discussion Dr. Bokhari shares what it’s like to be the first company to be dual-listed on the CSE and NASDAQ (1:35), the importance for companies in the capital markets to be in “the big ocean” (5:25), the groundbreaking clinical trials FSD Pharma is conducting with a synthetic compound that acts like CBD (6:30), and the “HUGE” importance of their ticker symbol (11:00).
Listen until the end to hear Dr. Bokhari’s personal path towards becoming a serial, “eccentric”, entrepreneur (12:30).